NHLBI stem cell consortium provides new insights into genetics of heart disease, other conditions
NIH-funded scientists has published the first studies using the largest,
most diverse stem cell collection of its kind ever made available to
researchers. The results provide fresh insights into the genetic
underpinnings of common conditions such as cardiovascular disease, high
blood pressure, diabetes, and sickle cell disease, which take a heavy
toll on American lives and resources.
In the future, discoveries from these studies of adult stem cells could lead to new ways to diagnose and treat disease, the researchers say. The first 11 studies resulting from this collaborative effort from multiple US institutions appear in the journals Cell Stem Cell, Stem Cell Reports, and EBioMedicine, which are published by Cell Press.
In 2011, the National Heart, Lung, Blood Institute (NHLBI), part of NIH, convened its Next Generation Genetic Association Studies (NextGen) Consortium with the goal of using induced pluripotent stem cells (link is external) (iPS cells) to better understand how complex genetic changes affect heart, lung, and blood cells. More than 1,000 iPS cell lines were obtained from more than 1,000 volunteers of different genders and ethnic backgrounds, making it one of the one of the most diverse stem cell collections ever studied. That diversity, the researchers note, ultimately will prove useful in helping reduce health disparities based on gender and ethnicity.
Though still in their early stages, the NextGen studies are already beginning to produce results. For example, one research group created a library of iPS cells from a geographically- and ethnically-diverse group of people with sickle cell disease. This well-characterized stem cell library could provide the basis for improved pre-clinical drug development for sickle cell disease, the study’s researchers say.
In addition to sickle cell disease, the cell lines from NextGen will prove helpful for studying other complex diseases, particularly cardiovascular disease. In the future, researchers hope to make these stem cell lines available for other researchers to study worldwide.
Cashell Jaquish, Ph.D., program director for the NHLBI’s NextGen Consortium, is available to comment on the findings and implications of this research.
About the National Heart, Lung, and Blood Institute (NHLBI): NHLBI, a part of the National Institutes of Health (NIH), plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics.
this is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.
https://gscrochetdesigns.
htps://gseasyrecipes.
https://kneereplacement-
In the future, discoveries from these studies of adult stem cells could lead to new ways to diagnose and treat disease, the researchers say. The first 11 studies resulting from this collaborative effort from multiple US institutions appear in the journals Cell Stem Cell, Stem Cell Reports, and EBioMedicine, which are published by Cell Press.
In 2011, the National Heart, Lung, Blood Institute (NHLBI), part of NIH, convened its Next Generation Genetic Association Studies (NextGen) Consortium with the goal of using induced pluripotent stem cells (link is external) (iPS cells) to better understand how complex genetic changes affect heart, lung, and blood cells. More than 1,000 iPS cell lines were obtained from more than 1,000 volunteers of different genders and ethnic backgrounds, making it one of the one of the most diverse stem cell collections ever studied. That diversity, the researchers note, ultimately will prove useful in helping reduce health disparities based on gender and ethnicity.
Though still in their early stages, the NextGen studies are already beginning to produce results. For example, one research group created a library of iPS cells from a geographically- and ethnically-diverse group of people with sickle cell disease. This well-characterized stem cell library could provide the basis for improved pre-clinical drug development for sickle cell disease, the study’s researchers say.
In addition to sickle cell disease, the cell lines from NextGen will prove helpful for studying other complex diseases, particularly cardiovascular disease. In the future, researchers hope to make these stem cell lines available for other researchers to study worldwide.
Cashell Jaquish, Ph.D., program director for the NHLBI’s NextGen Consortium, is available to comment on the findings and implications of this research.
About the National Heart, Lung, and Blood Institute (NHLBI): NHLBI, a part of the National Institutes of Health (NIH), plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics.
this is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.
https://gscrochetdesigns.
htps://gseasyrecipes.
https://kneereplacement-
Labels: blood disorder, cardiovascular diseases, diabetes, genetic changes, genetic underpinnings, High BP, pluripotent stem (iPS), prevention, sickle cell anemia, stem cell, treatment
posted by G S Iyer at 8:37 AM
0 Comments:
Post a Comment
<< Home